EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=538693, encodeId=8667538693b2, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：感觉这个杂志编辑的工作效率很低，而且不懂为什么会找不到审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=405, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9741690214, createdName=jata, createdTime=Sun Jul 09 18:31:00 CST 2017, time=2017-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590197, encodeId=7f2159019edd, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：投了一篇，一审时间长，revise后速度超级快，当天提交修回当天accept！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e6d5115388, createdName=14624272m57暂无昵称, createdTime=Mon May 04 00:00:00 CST 2020, time=2020-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839367, encodeId=adad83936e84, content=under review 65天後，回覆兩個reviewer的意見major revised 修改後重丟，兩天後接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f34b5414151, createdName=ms6267360147337765, createdTime=Thu Nov 16 23:54:37 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839366, encodeId=36318393669d, content=审稿速度:3.0 经验分享：under review 65天後，回覆兩個reviewer的意見major revised 修改後重丟，兩天後接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b45a5414020, createdName=ms9406847301318168, createdTime=Thu Nov 16 23:54:27 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548836, encodeId=88b75488360b, content=该杂志收中药药理的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=442, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06352187742, createdName=闲人遇仙人, createdTime=Thu Nov 02 15:14:00 CST 2017, time=2017-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=836146, encodeId=124f8361469e, content=周期确实比较长，不管是在编辑那还是在审稿人那，两次大修后接收的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de05414115, createdName=ms313574960747337, createdTime=Fri Apr 07 12:37:39 CST 2017, time=2017-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533942, encodeId=61bb533942e5, content=投稿网站换了新地址，投了三天了，还是With Journal，看评论不是一审一个月吗？zqlee 2017-01-25 发表:: 研究方向：药剂;生物药剂; 审稿时间：约1个月 ready for decision过程中。祈祷！！！, beContent=zqlee 2017-01-25 发表:: 研究方向：药剂;生物药剂; 审稿时间：约1个月 ready for decision过程中。祈祷！！！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=421, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00fe1724847, createdName=黄蓉, createdTime=Fri Mar 10 07:55:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532252, encodeId=9647532252c0, content=审稿速度:1.0 经验分享：ready for decision过程中。祈祷！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c8280048, createdName=zqlee, createdTime=Wed Jan 25 10:36:00 CST 2017, time=2017-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835369, encodeId=3ce583536942, content=很恶心的一个期刊，德国主编的杂志，审稿速度很慢，编辑不友善，根本不屌你，不是我的论文拒了我抱怨，我说的是实话，编辑根本不负责，而且严重歧视中国人，大家看看，中国人投稿，平均6个月录用，其它国家的人2-3个月。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb435413957, createdName=ms1699298910516592, createdTime=Sun Jan 22 15:21:41 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834863, encodeId=785d834863c8, content=哪里有那么快的啊，我投稿20天了，还在with editor，这是什么情况，我怕了，真是看了你们的评论，感觉上当了。 上面是我说的，最新的，热乎乎的，33天了，依然 with editor！我见过最恶心的杂志，我同学相同时间投的，已经小修了，我上辈子造孽了，投了一个听你们建议块的杂志，真是发誓以后MedSci再也不用！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08af5414079, createdName=ms3478754100835653, createdTime=Mon Dec 05 20:42:31 CST 2016, time=2016-12-05, status=1, ipAttribution=)]

2017-07-09 jata

审稿速度:12.0 | 投稿命中率:25.0
经验分享：感觉这个杂志编辑的工作效率很低，而且不懂为什么会找不到审稿人。

405 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=538693, encodeId=8667538693b2, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：感觉这个杂志编辑的工作效率很低，而且不懂为什么会找不到审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=405, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9741690214, createdName=jata, createdTime=Sun Jul 09 18:31:00 CST 2017, time=2017-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590197, encodeId=7f2159019edd, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：投了一篇，一审时间长，revise后速度超级快，当天提交修回当天accept！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e6d5115388, createdName=14624272m57暂无昵称, createdTime=Mon May 04 00:00:00 CST 2020, time=2020-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839367, encodeId=adad83936e84, content=under review 65天後，回覆兩個reviewer的意見major revised 修改後重丟，兩天後接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f34b5414151, createdName=ms6267360147337765, createdTime=Thu Nov 16 23:54:37 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839366, encodeId=36318393669d, content=审稿速度:3.0 经验分享：under review 65天後，回覆兩個reviewer的意見major revised 修改後重丟，兩天後接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b45a5414020, createdName=ms9406847301318168, createdTime=Thu Nov 16 23:54:27 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548836, encodeId=88b75488360b, content=该杂志收中药药理的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=442, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06352187742, createdName=闲人遇仙人, createdTime=Thu Nov 02 15:14:00 CST 2017, time=2017-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=836146, encodeId=124f8361469e, content=周期确实比较长，不管是在编辑那还是在审稿人那，两次大修后接收的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de05414115, createdName=ms313574960747337, createdTime=Fri Apr 07 12:37:39 CST 2017, time=2017-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533942, encodeId=61bb533942e5, content=投稿网站换了新地址，投了三天了，还是With Journal，看评论不是一审一个月吗？zqlee 2017-01-25 发表:: 研究方向：药剂;生物药剂; 审稿时间：约1个月 ready for decision过程中。祈祷！！！, beContent=zqlee 2017-01-25 发表:: 研究方向：药剂;生物药剂; 审稿时间：约1个月 ready for decision过程中。祈祷！！！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=421, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00fe1724847, createdName=黄蓉, createdTime=Fri Mar 10 07:55:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532252, encodeId=9647532252c0, content=审稿速度:1.0 经验分享：ready for decision过程中。祈祷！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c8280048, createdName=zqlee, createdTime=Wed Jan 25 10:36:00 CST 2017, time=2017-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835369, encodeId=3ce583536942, content=很恶心的一个期刊，德国主编的杂志，审稿速度很慢，编辑不友善，根本不屌你，不是我的论文拒了我抱怨，我说的是实话，编辑根本不负责，而且严重歧视中国人，大家看看，中国人投稿，平均6个月录用，其它国家的人2-3个月。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb435413957, createdName=ms1699298910516592, createdTime=Sun Jan 22 15:21:41 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834863, encodeId=785d834863c8, content=哪里有那么快的啊，我投稿20天了，还在with editor，这是什么情况，我怕了，真是看了你们的评论，感觉上当了。 上面是我说的，最新的，热乎乎的，33天了，依然 with editor！我见过最恶心的杂志，我同学相同时间投的，已经小修了，我上辈子造孽了，投了一个听你们建议块的杂志，真是发誓以后MedSci再也不用！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08af5414079, createdName=ms3478754100835653, createdTime=Mon Dec 05 20:42:31 CST 2016, time=2016-12-05, status=1, ipAttribution=)]

2020-05-04 14624272m57暂无昵称

审稿速度:6.0 | 投稿命中率:50.0
经验分享：投了一篇，一审时间长，revise后速度超级快，当天提交修回当天accept！

183 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=538693, encodeId=8667538693b2, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：感觉这个杂志编辑的工作效率很低，而且不懂为什么会找不到审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=405, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9741690214, createdName=jata, createdTime=Sun Jul 09 18:31:00 CST 2017, time=2017-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590197, encodeId=7f2159019edd, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：投了一篇，一审时间长，revise后速度超级快，当天提交修回当天accept！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e6d5115388, createdName=14624272m57暂无昵称, createdTime=Mon May 04 00:00:00 CST 2020, time=2020-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839367, encodeId=adad83936e84, content=under review 65天後，回覆兩個reviewer的意見major revised 修改後重丟，兩天後接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f34b5414151, createdName=ms6267360147337765, createdTime=Thu Nov 16 23:54:37 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839366, encodeId=36318393669d, content=审稿速度:3.0 经验分享：under review 65天後，回覆兩個reviewer的意見major revised 修改後重丟，兩天後接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b45a5414020, createdName=ms9406847301318168, createdTime=Thu Nov 16 23:54:27 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548836, encodeId=88b75488360b, content=该杂志收中药药理的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=442, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06352187742, createdName=闲人遇仙人, createdTime=Thu Nov 02 15:14:00 CST 2017, time=2017-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=836146, encodeId=124f8361469e, content=周期确实比较长，不管是在编辑那还是在审稿人那，两次大修后接收的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de05414115, createdName=ms313574960747337, createdTime=Fri Apr 07 12:37:39 CST 2017, time=2017-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533942, encodeId=61bb533942e5, content=投稿网站换了新地址，投了三天了，还是With Journal，看评论不是一审一个月吗？zqlee 2017-01-25 发表:: 研究方向：药剂;生物药剂; 审稿时间：约1个月 ready for decision过程中。祈祷！！！, beContent=zqlee 2017-01-25 发表:: 研究方向：药剂;生物药剂; 审稿时间：约1个月 ready for decision过程中。祈祷！！！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=421, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00fe1724847, createdName=黄蓉, createdTime=Fri Mar 10 07:55:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532252, encodeId=9647532252c0, content=审稿速度:1.0 经验分享：ready for decision过程中。祈祷！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c8280048, createdName=zqlee, createdTime=Wed Jan 25 10:36:00 CST 2017, time=2017-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835369, encodeId=3ce583536942, content=很恶心的一个期刊，德国主编的杂志，审稿速度很慢，编辑不友善，根本不屌你，不是我的论文拒了我抱怨，我说的是实话，编辑根本不负责，而且严重歧视中国人，大家看看，中国人投稿，平均6个月录用，其它国家的人2-3个月。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb435413957, createdName=ms1699298910516592, createdTime=Sun Jan 22 15:21:41 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834863, encodeId=785d834863c8, content=哪里有那么快的啊，我投稿20天了，还在with editor，这是什么情况，我怕了，真是看了你们的评论，感觉上当了。 上面是我说的，最新的，热乎乎的，33天了，依然 with editor！我见过最恶心的杂志，我同学相同时间投的，已经小修了，我上辈子造孽了，投了一个听你们建议块的杂志，真是发誓以后MedSci再也不用！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08af5414079, createdName=ms3478754100835653, createdTime=Mon Dec 05 20:42:31 CST 2016, time=2016-12-05, status=1, ipAttribution=)]

2017-11-16 ms6267360147337765

under review 65天後，回覆兩個reviewer的意見major revised
修改後重丟，兩天後接受

198 0

[GetPortalCommentsPageByObjectIdResponse(id=538693, encodeId=8667538693b2, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：感觉这个杂志编辑的工作效率很低，而且不懂为什么会找不到审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=405, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9741690214, createdName=jata, createdTime=Sun Jul 09 18:31:00 CST 2017, time=2017-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590197, encodeId=7f2159019edd, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：投了一篇，一审时间长，revise后速度超级快，当天提交修回当天accept！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e6d5115388, createdName=14624272m57暂无昵称, createdTime=Mon May 04 00:00:00 CST 2020, time=2020-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839367, encodeId=adad83936e84, content=under review 65天後，回覆兩個reviewer的意見major revised 修改後重丟，兩天後接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f34b5414151, createdName=ms6267360147337765, createdTime=Thu Nov 16 23:54:37 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839366, encodeId=36318393669d, content=审稿速度:3.0 经验分享：under review 65天後，回覆兩個reviewer的意見major revised 修改後重丟，兩天後接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b45a5414020, createdName=ms9406847301318168, createdTime=Thu Nov 16 23:54:27 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548836, encodeId=88b75488360b, content=该杂志收中药药理的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=442, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06352187742, createdName=闲人遇仙人, createdTime=Thu Nov 02 15:14:00 CST 2017, time=2017-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=836146, encodeId=124f8361469e, content=周期确实比较长，不管是在编辑那还是在审稿人那，两次大修后接收的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de05414115, createdName=ms313574960747337, createdTime=Fri Apr 07 12:37:39 CST 2017, time=2017-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533942, encodeId=61bb533942e5, content=投稿网站换了新地址，投了三天了，还是With Journal，看评论不是一审一个月吗？zqlee 2017-01-25 发表:: 研究方向：药剂;生物药剂; 审稿时间：约1个月 ready for decision过程中。祈祷！！！, beContent=zqlee 2017-01-25 发表:: 研究方向：药剂;生物药剂; 审稿时间：约1个月 ready for decision过程中。祈祷！！！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=421, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00fe1724847, createdName=黄蓉, createdTime=Fri Mar 10 07:55:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532252, encodeId=9647532252c0, content=审稿速度:1.0 经验分享：ready for decision过程中。祈祷！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c8280048, createdName=zqlee, createdTime=Wed Jan 25 10:36:00 CST 2017, time=2017-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835369, encodeId=3ce583536942, content=很恶心的一个期刊，德国主编的杂志，审稿速度很慢，编辑不友善，根本不屌你，不是我的论文拒了我抱怨，我说的是实话，编辑根本不负责，而且严重歧视中国人，大家看看，中国人投稿，平均6个月录用，其它国家的人2-3个月。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb435413957, createdName=ms1699298910516592, createdTime=Sun Jan 22 15:21:41 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834863, encodeId=785d834863c8, content=哪里有那么快的啊，我投稿20天了，还在with editor，这是什么情况，我怕了，真是看了你们的评论，感觉上当了。 上面是我说的，最新的，热乎乎的，33天了，依然 with editor！我见过最恶心的杂志，我同学相同时间投的，已经小修了，我上辈子造孽了，投了一个听你们建议块的杂志，真是发誓以后MedSci再也不用！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08af5414079, createdName=ms3478754100835653, createdTime=Mon Dec 05 20:42:31 CST 2016, time=2016-12-05, status=1, ipAttribution=)]

2017-11-16 ms9406847301318168

审稿速度:3.0
经验分享：under review 65天後，回覆兩個reviewer的意見major revised
修改後重丟，兩天後接受

168 0

[GetPortalCommentsPageByObjectIdResponse(id=538693, encodeId=8667538693b2, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：感觉这个杂志编辑的工作效率很低，而且不懂为什么会找不到审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=405, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9741690214, createdName=jata, createdTime=Sun Jul 09 18:31:00 CST 2017, time=2017-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590197, encodeId=7f2159019edd, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：投了一篇，一审时间长，revise后速度超级快，当天提交修回当天accept！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e6d5115388, createdName=14624272m57暂无昵称, createdTime=Mon May 04 00:00:00 CST 2020, time=2020-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839367, encodeId=adad83936e84, content=under review 65天後，回覆兩個reviewer的意見major revised 修改後重丟，兩天後接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f34b5414151, createdName=ms6267360147337765, createdTime=Thu Nov 16 23:54:37 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839366, encodeId=36318393669d, content=审稿速度:3.0 经验分享：under review 65天後，回覆兩個reviewer的意見major revised 修改後重丟，兩天後接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b45a5414020, createdName=ms9406847301318168, createdTime=Thu Nov 16 23:54:27 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548836, encodeId=88b75488360b, content=该杂志收中药药理的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=442, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06352187742, createdName=闲人遇仙人, createdTime=Thu Nov 02 15:14:00 CST 2017, time=2017-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=836146, encodeId=124f8361469e, content=周期确实比较长，不管是在编辑那还是在审稿人那，两次大修后接收的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de05414115, createdName=ms313574960747337, createdTime=Fri Apr 07 12:37:39 CST 2017, time=2017-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533942, encodeId=61bb533942e5, content=投稿网站换了新地址，投了三天了，还是With Journal，看评论不是一审一个月吗？zqlee 2017-01-25 发表:: 研究方向：药剂;生物药剂; 审稿时间：约1个月 ready for decision过程中。祈祷！！！, beContent=zqlee 2017-01-25 发表:: 研究方向：药剂;生物药剂; 审稿时间：约1个月 ready for decision过程中。祈祷！！！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=421, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00fe1724847, createdName=黄蓉, createdTime=Fri Mar 10 07:55:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532252, encodeId=9647532252c0, content=审稿速度:1.0 经验分享：ready for decision过程中。祈祷！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c8280048, createdName=zqlee, createdTime=Wed Jan 25 10:36:00 CST 2017, time=2017-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835369, encodeId=3ce583536942, content=很恶心的一个期刊，德国主编的杂志，审稿速度很慢，编辑不友善，根本不屌你，不是我的论文拒了我抱怨，我说的是实话，编辑根本不负责，而且严重歧视中国人，大家看看，中国人投稿，平均6个月录用，其它国家的人2-3个月。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb435413957, createdName=ms1699298910516592, createdTime=Sun Jan 22 15:21:41 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834863, encodeId=785d834863c8, content=哪里有那么快的啊，我投稿20天了，还在with editor，这是什么情况，我怕了，真是看了你们的评论，感觉上当了。 上面是我说的，最新的，热乎乎的，33天了，依然 with editor！我见过最恶心的杂志，我同学相同时间投的，已经小修了，我上辈子造孽了，投了一个听你们建议块的杂志，真是发誓以后MedSci再也不用！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08af5414079, createdName=ms3478754100835653, createdTime=Mon Dec 05 20:42:31 CST 2016, time=2016-12-05, status=1, ipAttribution=)]

2017-11-02 闲人遇仙人

该杂志收中药药理的吗？

442 0

[GetPortalCommentsPageByObjectIdResponse(id=538693, encodeId=8667538693b2, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：感觉这个杂志编辑的工作效率很低，而且不懂为什么会找不到审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=405, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9741690214, createdName=jata, createdTime=Sun Jul 09 18:31:00 CST 2017, time=2017-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590197, encodeId=7f2159019edd, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：投了一篇，一审时间长，revise后速度超级快，当天提交修回当天accept！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e6d5115388, createdName=14624272m57暂无昵称, createdTime=Mon May 04 00:00:00 CST 2020, time=2020-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839367, encodeId=adad83936e84, content=under review 65天後，回覆兩個reviewer的意見major revised 修改後重丟，兩天後接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f34b5414151, createdName=ms6267360147337765, createdTime=Thu Nov 16 23:54:37 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839366, encodeId=36318393669d, content=审稿速度:3.0 经验分享：under review 65天後，回覆兩個reviewer的意見major revised 修改後重丟，兩天後接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b45a5414020, createdName=ms9406847301318168, createdTime=Thu Nov 16 23:54:27 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548836, encodeId=88b75488360b, content=该杂志收中药药理的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=442, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06352187742, createdName=闲人遇仙人, createdTime=Thu Nov 02 15:14:00 CST 2017, time=2017-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=836146, encodeId=124f8361469e, content=周期确实比较长，不管是在编辑那还是在审稿人那，两次大修后接收的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de05414115, createdName=ms313574960747337, createdTime=Fri Apr 07 12:37:39 CST 2017, time=2017-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533942, encodeId=61bb533942e5, content=投稿网站换了新地址，投了三天了，还是With Journal，看评论不是一审一个月吗？zqlee 2017-01-25 发表:: 研究方向：药剂;生物药剂; 审稿时间：约1个月 ready for decision过程中。祈祷！！！, beContent=zqlee 2017-01-25 发表:: 研究方向：药剂;生物药剂; 审稿时间：约1个月 ready for decision过程中。祈祷！！！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=421, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00fe1724847, createdName=黄蓉, createdTime=Fri Mar 10 07:55:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532252, encodeId=9647532252c0, content=审稿速度:1.0 经验分享：ready for decision过程中。祈祷！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c8280048, createdName=zqlee, createdTime=Wed Jan 25 10:36:00 CST 2017, time=2017-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835369, encodeId=3ce583536942, content=很恶心的一个期刊，德国主编的杂志，审稿速度很慢，编辑不友善，根本不屌你，不是我的论文拒了我抱怨，我说的是实话，编辑根本不负责，而且严重歧视中国人，大家看看，中国人投稿，平均6个月录用，其它国家的人2-3个月。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb435413957, createdName=ms1699298910516592, createdTime=Sun Jan 22 15:21:41 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834863, encodeId=785d834863c8, content=哪里有那么快的啊，我投稿20天了，还在with editor，这是什么情况，我怕了，真是看了你们的评论，感觉上当了。 上面是我说的，最新的，热乎乎的，33天了，依然 with editor！我见过最恶心的杂志，我同学相同时间投的，已经小修了，我上辈子造孽了，投了一个听你们建议块的杂志，真是发誓以后MedSci再也不用！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08af5414079, createdName=ms3478754100835653, createdTime=Mon Dec 05 20:42:31 CST 2016, time=2016-12-05, status=1, ipAttribution=)]

2017-04-07 ms313574960747337

周期确实比较长，不管是在编辑那还是在审稿人那，两次大修后接收的

187 0

[GetPortalCommentsPageByObjectIdResponse(id=538693, encodeId=8667538693b2, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：感觉这个杂志编辑的工作效率很低，而且不懂为什么会找不到审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=405, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9741690214, createdName=jata, createdTime=Sun Jul 09 18:31:00 CST 2017, time=2017-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590197, encodeId=7f2159019edd, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：投了一篇，一审时间长，revise后速度超级快，当天提交修回当天accept！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e6d5115388, createdName=14624272m57暂无昵称, createdTime=Mon May 04 00:00:00 CST 2020, time=2020-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839367, encodeId=adad83936e84, content=under review 65天後，回覆兩個reviewer的意見major revised 修改後重丟，兩天後接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f34b5414151, createdName=ms6267360147337765, createdTime=Thu Nov 16 23:54:37 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839366, encodeId=36318393669d, content=审稿速度:3.0 经验分享：under review 65天後，回覆兩個reviewer的意見major revised 修改後重丟，兩天後接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b45a5414020, createdName=ms9406847301318168, createdTime=Thu Nov 16 23:54:27 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548836, encodeId=88b75488360b, content=该杂志收中药药理的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=442, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06352187742, createdName=闲人遇仙人, createdTime=Thu Nov 02 15:14:00 CST 2017, time=2017-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=836146, encodeId=124f8361469e, content=周期确实比较长，不管是在编辑那还是在审稿人那，两次大修后接收的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de05414115, createdName=ms313574960747337, createdTime=Fri Apr 07 12:37:39 CST 2017, time=2017-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533942, encodeId=61bb533942e5, content=投稿网站换了新地址，投了三天了，还是With Journal，看评论不是一审一个月吗？zqlee 2017-01-25 发表:: 研究方向：药剂;生物药剂; 审稿时间：约1个月 ready for decision过程中。祈祷！！！, beContent=zqlee 2017-01-25 发表:: 研究方向：药剂;生物药剂; 审稿时间：约1个月 ready for decision过程中。祈祷！！！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=421, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00fe1724847, createdName=黄蓉, createdTime=Fri Mar 10 07:55:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532252, encodeId=9647532252c0, content=审稿速度:1.0 经验分享：ready for decision过程中。祈祷！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c8280048, createdName=zqlee, createdTime=Wed Jan 25 10:36:00 CST 2017, time=2017-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835369, encodeId=3ce583536942, content=很恶心的一个期刊，德国主编的杂志，审稿速度很慢，编辑不友善，根本不屌你，不是我的论文拒了我抱怨，我说的是实话，编辑根本不负责，而且严重歧视中国人，大家看看，中国人投稿，平均6个月录用，其它国家的人2-3个月。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb435413957, createdName=ms1699298910516592, createdTime=Sun Jan 22 15:21:41 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834863, encodeId=785d834863c8, content=哪里有那么快的啊，我投稿20天了，还在with editor，这是什么情况，我怕了，真是看了你们的评论，感觉上当了。 上面是我说的，最新的，热乎乎的，33天了，依然 with editor！我见过最恶心的杂志，我同学相同时间投的，已经小修了，我上辈子造孽了，投了一个听你们建议块的杂志，真是发誓以后MedSci再也不用！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08af5414079, createdName=ms3478754100835653, createdTime=Mon Dec 05 20:42:31 CST 2016, time=2016-12-05, status=1, ipAttribution=)]

2017-03-10 黄蓉

投稿网站换了新地址，投了三天了，还是With Journal，看评论不是一审一个月吗？zqlee 2017-01-25 发表::
研究方向：药剂;生物药剂; 审稿时间：约1个月 ready for decision过程中。祈祷！！！

zqlee 2017-01-25 发表:: 研究方向：药剂;生物药剂; 审稿时间：约1个月 ready for decision过程中。祈祷！！！

421 0

[GetPortalCommentsPageByObjectIdResponse(id=538693, encodeId=8667538693b2, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：感觉这个杂志编辑的工作效率很低，而且不懂为什么会找不到审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=405, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9741690214, createdName=jata, createdTime=Sun Jul 09 18:31:00 CST 2017, time=2017-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590197, encodeId=7f2159019edd, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：投了一篇，一审时间长，revise后速度超级快，当天提交修回当天accept！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e6d5115388, createdName=14624272m57暂无昵称, createdTime=Mon May 04 00:00:00 CST 2020, time=2020-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839367, encodeId=adad83936e84, content=under review 65天後，回覆兩個reviewer的意見major revised 修改後重丟，兩天後接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f34b5414151, createdName=ms6267360147337765, createdTime=Thu Nov 16 23:54:37 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839366, encodeId=36318393669d, content=审稿速度:3.0 经验分享：under review 65天後，回覆兩個reviewer的意見major revised 修改後重丟，兩天後接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b45a5414020, createdName=ms9406847301318168, createdTime=Thu Nov 16 23:54:27 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548836, encodeId=88b75488360b, content=该杂志收中药药理的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=442, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06352187742, createdName=闲人遇仙人, createdTime=Thu Nov 02 15:14:00 CST 2017, time=2017-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=836146, encodeId=124f8361469e, content=周期确实比较长，不管是在编辑那还是在审稿人那，两次大修后接收的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de05414115, createdName=ms313574960747337, createdTime=Fri Apr 07 12:37:39 CST 2017, time=2017-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533942, encodeId=61bb533942e5, content=投稿网站换了新地址，投了三天了，还是With Journal，看评论不是一审一个月吗？zqlee 2017-01-25 发表:: 研究方向：药剂;生物药剂; 审稿时间：约1个月 ready for decision过程中。祈祷！！！, beContent=zqlee 2017-01-25 发表:: 研究方向：药剂;生物药剂; 审稿时间：约1个月 ready for decision过程中。祈祷！！！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=421, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00fe1724847, createdName=黄蓉, createdTime=Fri Mar 10 07:55:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532252, encodeId=9647532252c0, content=审稿速度:1.0 经验分享：ready for decision过程中。祈祷！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c8280048, createdName=zqlee, createdTime=Wed Jan 25 10:36:00 CST 2017, time=2017-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835369, encodeId=3ce583536942, content=很恶心的一个期刊，德国主编的杂志，审稿速度很慢，编辑不友善，根本不屌你，不是我的论文拒了我抱怨，我说的是实话，编辑根本不负责，而且严重歧视中国人，大家看看，中国人投稿，平均6个月录用，其它国家的人2-3个月。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb435413957, createdName=ms1699298910516592, createdTime=Sun Jan 22 15:21:41 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834863, encodeId=785d834863c8, content=哪里有那么快的啊，我投稿20天了，还在with editor，这是什么情况，我怕了，真是看了你们的评论，感觉上当了。 上面是我说的，最新的，热乎乎的，33天了，依然 with editor！我见过最恶心的杂志，我同学相同时间投的，已经小修了，我上辈子造孽了，投了一个听你们建议块的杂志，真是发誓以后MedSci再也不用！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08af5414079, createdName=ms3478754100835653, createdTime=Mon Dec 05 20:42:31 CST 2016, time=2016-12-05, status=1, ipAttribution=)]

2017-01-25 zqlee

审稿速度:1.0
经验分享：ready for decision过程中。祈祷！！！

447 0

[GetPortalCommentsPageByObjectIdResponse(id=538693, encodeId=8667538693b2, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：感觉这个杂志编辑的工作效率很低，而且不懂为什么会找不到审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=405, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9741690214, createdName=jata, createdTime=Sun Jul 09 18:31:00 CST 2017, time=2017-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590197, encodeId=7f2159019edd, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：投了一篇，一审时间长，revise后速度超级快，当天提交修回当天accept！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e6d5115388, createdName=14624272m57暂无昵称, createdTime=Mon May 04 00:00:00 CST 2020, time=2020-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839367, encodeId=adad83936e84, content=under review 65天後，回覆兩個reviewer的意見major revised 修改後重丟，兩天後接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f34b5414151, createdName=ms6267360147337765, createdTime=Thu Nov 16 23:54:37 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839366, encodeId=36318393669d, content=审稿速度:3.0 经验分享：under review 65天後，回覆兩個reviewer的意見major revised 修改後重丟，兩天後接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b45a5414020, createdName=ms9406847301318168, createdTime=Thu Nov 16 23:54:27 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548836, encodeId=88b75488360b, content=该杂志收中药药理的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=442, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06352187742, createdName=闲人遇仙人, createdTime=Thu Nov 02 15:14:00 CST 2017, time=2017-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=836146, encodeId=124f8361469e, content=周期确实比较长，不管是在编辑那还是在审稿人那，两次大修后接收的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de05414115, createdName=ms313574960747337, createdTime=Fri Apr 07 12:37:39 CST 2017, time=2017-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533942, encodeId=61bb533942e5, content=投稿网站换了新地址，投了三天了，还是With Journal，看评论不是一审一个月吗？zqlee 2017-01-25 发表:: 研究方向：药剂;生物药剂; 审稿时间：约1个月 ready for decision过程中。祈祷！！！, beContent=zqlee 2017-01-25 发表:: 研究方向：药剂;生物药剂; 审稿时间：约1个月 ready for decision过程中。祈祷！！！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=421, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00fe1724847, createdName=黄蓉, createdTime=Fri Mar 10 07:55:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532252, encodeId=9647532252c0, content=审稿速度:1.0 经验分享：ready for decision过程中。祈祷！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c8280048, createdName=zqlee, createdTime=Wed Jan 25 10:36:00 CST 2017, time=2017-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835369, encodeId=3ce583536942, content=很恶心的一个期刊，德国主编的杂志，审稿速度很慢，编辑不友善，根本不屌你，不是我的论文拒了我抱怨，我说的是实话，编辑根本不负责，而且严重歧视中国人，大家看看，中国人投稿，平均6个月录用，其它国家的人2-3个月。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb435413957, createdName=ms1699298910516592, createdTime=Sun Jan 22 15:21:41 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834863, encodeId=785d834863c8, content=哪里有那么快的啊，我投稿20天了，还在with editor，这是什么情况，我怕了，真是看了你们的评论，感觉上当了。 上面是我说的，最新的，热乎乎的，33天了，依然 with editor！我见过最恶心的杂志，我同学相同时间投的，已经小修了，我上辈子造孽了，投了一个听你们建议块的杂志，真是发誓以后MedSci再也不用！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08af5414079, createdName=ms3478754100835653, createdTime=Mon Dec 05 20:42:31 CST 2016, time=2016-12-05, status=1, ipAttribution=)]

2017-01-22 ms1699298910516592

很恶心的一个期刊，德国主编的杂志，审稿速度很慢，编辑不友善，根本不屌你，不是我的论文拒了我抱怨，我说的是实话，编辑根本不负责，而且严重歧视中国人，大家看看，中国人投稿，平均6个月录用，其它国家的人2-3个月。

167 0

[GetPortalCommentsPageByObjectIdResponse(id=538693, encodeId=8667538693b2, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：感觉这个杂志编辑的工作效率很低，而且不懂为什么会找不到审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=405, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9741690214, createdName=jata, createdTime=Sun Jul 09 18:31:00 CST 2017, time=2017-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590197, encodeId=7f2159019edd, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：投了一篇，一审时间长，revise后速度超级快，当天提交修回当天accept！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e6d5115388, createdName=14624272m57暂无昵称, createdTime=Mon May 04 00:00:00 CST 2020, time=2020-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839367, encodeId=adad83936e84, content=under review 65天後，回覆兩個reviewer的意見major revised 修改後重丟，兩天後接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f34b5414151, createdName=ms6267360147337765, createdTime=Thu Nov 16 23:54:37 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839366, encodeId=36318393669d, content=审稿速度:3.0 经验分享：under review 65天後，回覆兩個reviewer的意見major revised 修改後重丟，兩天後接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b45a5414020, createdName=ms9406847301318168, createdTime=Thu Nov 16 23:54:27 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548836, encodeId=88b75488360b, content=该杂志收中药药理的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=442, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06352187742, createdName=闲人遇仙人, createdTime=Thu Nov 02 15:14:00 CST 2017, time=2017-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=836146, encodeId=124f8361469e, content=周期确实比较长，不管是在编辑那还是在审稿人那，两次大修后接收的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de05414115, createdName=ms313574960747337, createdTime=Fri Apr 07 12:37:39 CST 2017, time=2017-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533942, encodeId=61bb533942e5, content=投稿网站换了新地址，投了三天了，还是With Journal，看评论不是一审一个月吗？zqlee 2017-01-25 发表:: 研究方向：药剂;生物药剂; 审稿时间：约1个月 ready for decision过程中。祈祷！！！, beContent=zqlee 2017-01-25 发表:: 研究方向：药剂;生物药剂; 审稿时间：约1个月 ready for decision过程中。祈祷！！！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=421, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00fe1724847, createdName=黄蓉, createdTime=Fri Mar 10 07:55:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532252, encodeId=9647532252c0, content=审稿速度:1.0 经验分享：ready for decision过程中。祈祷！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c8280048, createdName=zqlee, createdTime=Wed Jan 25 10:36:00 CST 2017, time=2017-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835369, encodeId=3ce583536942, content=很恶心的一个期刊，德国主编的杂志，审稿速度很慢，编辑不友善，根本不屌你，不是我的论文拒了我抱怨，我说的是实话，编辑根本不负责，而且严重歧视中国人，大家看看，中国人投稿，平均6个月录用，其它国家的人2-3个月。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb435413957, createdName=ms1699298910516592, createdTime=Sun Jan 22 15:21:41 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834863, encodeId=785d834863c8, content=哪里有那么快的啊，我投稿20天了，还在with editor，这是什么情况，我怕了，真是看了你们的评论，感觉上当了。 上面是我说的，最新的，热乎乎的，33天了，依然 with editor！我见过最恶心的杂志，我同学相同时间投的，已经小修了，我上辈子造孽了，投了一个听你们建议块的杂志，真是发誓以后MedSci再也不用！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08af5414079, createdName=ms3478754100835653, createdTime=Mon Dec 05 20:42:31 CST 2016, time=2016-12-05, status=1, ipAttribution=)]

2016-12-05 ms3478754100835653

哪里有那么快的啊，我投稿20天了，还在with editor，这是什么情况，我怕了，真是看了你们的评论，感觉上当了。
上面是我说的，最新的，热乎乎的，33天了，依然 with editor！我见过最恶心的杂志，我同学相同时间投的，已经小修了，我上辈子造孽了，投了一个听你们建议块的杂志，真是发誓以后MedSci再也不用！

136 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务